Vaxxinity Inc (VAXX)

Vaxxinity Inc (VAXX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12,678; returns 1 day +0.0%.

Vaxxinity Inc. is a clinical-stage biotechnology company focused on developing synthetic peptide-based active immunotherapy medicines. Their technology aims to create vaccines for chronic diseases like Alzheimer's, Parkinson's, migraine, and hypercholesterolemia.

Groups VAXX belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• Immunotherapy
• Healthcare
• Life Sciences
• Neuroscience
• CNS Disorders
• Neurological Disorders
• Alzheimer's Disease
• Chronic Disease Management

VAXX financial model: income statement, cash flow and balance sheet